Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 May 7:S0025-6196(25)00185-5.
doi: 10.1016/j.mayocp.2025.03.030. Online ahead of print.

Mayo Clinic Proceedings and Steatohepatitis: From NASH Recognition to MASH Therapy

Hanna L Erickson  1 , Thomas R Viggiano  1 , Harmeet Malhi  2
Affiliations
Editorial

Mayo Clinic Proceedings and Steatohepatitis: From NASH Recognition to MASH Therapy

Hanna L Erickson et al. Mayo Clin Proc. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

POTENTIAL COMPETING INTERESTS

The authors report no competing interests.

Figures

FIGURE.
FIGURE.
A, Number of papers published annually. Source: PubMed.gov. Search terms: NASH—nonalcoholic steatohepatitis and non-alcoholic steatohepatitis; MASH—metabolic dysfunction–associated steatohepatitis. B, Timeline of major papers in history of nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction–associated steatotic liver disease (MASLD). CRN, Clinical Research Network; FDA, Food and Drug Administration; GWAS, genome-wide association study; MR, magnetic resonance; NAS, NAFLD activity score.
See this image and copyright information in PMC

References

    1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55(7):434–438. - PubMed
    1. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis. 1986;8:283–298. - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–1986. - PMC - PubMed
    1. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009;51(2):371–379. - PubMed
    1. Sanyal AJ, Van Natta ML, Clark J, et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med. 2021;385(17):1559–1569. - PMC - PubMed

Publication types

LinkOut - more resources